According to Pfizer CEO, the company can deliver 10% more cans to the US by the end of May than previously agreed
The bottles for the Pfizer BioNTech COVID-19 vaccine can be prepared prior to the opening of a mass vaccination site in Queens, New York on February 24, 2021.
Seth Little | Pool | Reuters
Albert Bourla, CEO of Pfizer, said Tuesday that his company had ramped up production of its two-shot coronavirus vaccine and could ship a total of 300 million doses to the U.S. ahead of schedule.
Bourla said on Twitter that Pfizer can ship 10% more cans to the US by the end of May than previously agreed – up to 220 million out of 200 million.
The company will be able to ship the full $ 300 million to the US two weeks early, Bourla said.
“We’re in the fight against COVID-19 together,” he tweeted.
The announcement came when dozen of states temporarily stopped giving Johnson & Johnson’s single-dose Covid vaccine. The Food and Drug Administration advised them to do so on Tuesday after six women in the United States developed a rare bleeding disorder in which one woman was dead and another in critical condition.
Some states, like New York, said they would use Pfizer’s vaccine instead of the J&J shot for appointments that were already scheduled.